Stock Detail
UROPLASTY INC
Sector: Medical Instruments Supls
Latest Quote @ Wed May 5 04:53:42 (15 min delayed)
| $ |
$2.51 |
$2.18 |
+0.11 |
5.31% |
|
Last Day's Data
| $2.18 |
$2.25 |
$0.11 |
5.31% |
0.00 |
$2.07 |
| $2.16 |
$2.15 |
11,072.00 |
45.58M |
31,778.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 2.29 |
2.23 |
2.19 |
2.13 |
2.09 |
Stock Profile
Uroplasty, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of voiding dysfunctions, including urinary and fecal incontinence, and overactive bladder symptoms. It primarily offers Macroplastique implants, a minimally invasive, implantable soft tissue bulking agent for the treatment of urinary incontinence; PTQ implants for the treatment of fecal incontinence; VOX implants for the treatment of vocal cord rehabilitation; and Bioplastique implants for dermal augmentation. The company also offers Urgent PC neuromodulation system, a device designed for office-based treatment of overactive bladder symptoms of urinary urge incontinence, urinary urgency, and urinary frequency; and I-Stop, a biocompatible, polypropylene, tension-free sling for the treatment of female urinary incontinence. Uroplasty markets its products through direct field sales and independent sales representatives in the United States; and a direct sales organization in the United Kingdom, as well as through distributors in other markets. The company was incorporated in 1992 and is headquartered in Minnetonka, Minnesota.
